Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 67 clinical trials
Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD Heart Failure ObGyn IBD Cancer and Elective Surgery (Real-CHOICE).

general and IIM (iron isomaltoside 1000) treatment particularly before and after IIM treatment in iron deficient patients with or without anemia in the real-world clinical setting after commercial

iron therapy
cancer
iron isomaltoside 1000
monofer
heart failure
  • 0 views
  • 01 Apr, 2021
  • 14 locations
Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) (CDASI)

The Evaluation of Clinical Responsiveness Using the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), established in 2008, is a one-site database study conducted at the University of Pennsylvania. The database has yielded valuable information and clinical insights into the pathophysiology, disease processes, including psychological responses, treatments and quality of …

dermatomyositis
  • 1 views
  • 23 Mar, 2022
  • 1 location
The Pathogenesis of Depression - Possible Autoimmune Mechanisms

' syndrome (SS), systemic sclerosis (SSc), inflammatory myopathies (IIM), any Overlap of the above including mixed connective tissue disease (MCTD), systemic vasculitis (see Chapel Hill classification

diabetes
depressed mood
depressive symptoms
arthritis
progressive systemic sclerosis
  • 0 views
  • 09 Apr, 2022
  • 1 location
Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

, including patients with the following neuromuscular disorders: histologically confirmed inclusion body myositis (IBM), genetically confirmed late-onset Pompe disease (LOPD), genetically confirmed spinal

dyspnea
exercise tests
  • 0 views
  • 18 Jun, 2021
  • 1 location
PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS (PRODIGIOUS)

To date, there is no available tool that allows, at individual level, determination of the probability to develop clinically relevant complications of prolonged glucocorticoid therapy. In patients with inflammatory rheumatic disorders requiring prolonged glucocorticoid therapy, such tool could be useful to adapt first-line treatment decisions (in daily practice and in …

glucocorticoid therapy
glucocorticoids
  • 0 views
  • 26 May, 2022
  • 9 locations
Evaluation of Hand Functions in Newly Diagnosed Primary Sj gren's Syndrome

joint involvement of PSS is usually moderate (<5 affected joints) and mostly affects the small joints of the hands and upper extremities. PSS may also be responsible for myositis. Widespread pain

arthralgia
stiffness
Accepts healthy volunteers
rheumatic diseases
autoimmune disease
  • 2 views
  • 18 Nov, 2021
  • 1 location
Muscle Weakness in COVID-19 Patients (MIOCOVID)

), but also to the direct action of virus (SARS-Cov-2 myositis). The general purpose of the research is to quantify the spread of symptoms and signs of muscle weakness and pain among the patient

  • 0 views
  • 27 May, 2022
  • 1 location
ILD-SARDs Registry and Biorepository

A complex interaction between demographic, environmental and genetic mechanisms impact the onset, severity and outcome of ILD-SARDs through dysregulation of the immune system and lung pro-biotic pathways. Comorbidity and genetic risk indicate that there are overlapping pathogenic mechanisms among SARDs, some of which underlie ILD in different SARDs. The purpose …

connective tissue disease
chest ct
lung disease
bronchoalveolar lavage
  • 0 views
  • 18 Sep, 2021
  • 1 location
Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

This is a Phase 2/3, double-blind, randomized, placebo-controlled, parallel group, multicenter study to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of ravulizumab in adult participants with dermatomyositis (DM).

corticosteroids
azathioprine
rituximab
dermatomyositis
methotrexate
  • 2 views
  • 11 Jul, 2022
  • 30 locations
An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

The purpose of this research study is to evaluate the long-term safety, and tolerability of PF-06823859 study drug in adult participants with Dermatomyositis (DM) from a qualifying study.

dermatomyositis
  • 0 views
  • 10 Aug, 2022
  • 21 locations